The FLOW Registry.

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18+
SponsorUniversity of Chicago

About this trial

The purpose of this study is to create a database and prospective registry for data collection on patients with benign prostatic hyperplasia undergoing Aquablation of the prostate. All patients undergoing Aquablation of the prostate will be enrolled in the registry. Historical data from 1/1/2024- 11/30/2025 will be added through chart review. Current and future patient data will be collected through chart review during the subject's clinical care. Only data available in the electronic medical record will be collected and no additional data will be collected for research purposes. No biospecimens will be collected, and there are no physical risks from study participation.

Eligibility criteria

Qualifiers

Male sex

≥18 years of age

Diagnosis of benign prostatic hyperplasia

Scheduled to undergo or have already undergone Aquablation as part of routine clinical care or any ongoing clinical trials

Disqualifiers

Under 18 Years of age.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

3,000 Participants
are grouped into 1 trial group

Sponsors and collaborators